Alogliptin benzoate (Alogliptin) Φαρμακευτικές πρώτες ύλες | Oral anti-diabetic drug

» Φαρμακευτικός » Άλλες APIs » Alogliptin benzoate (Alogliptin) Φαρμακευτικές πρώτες ύλες | Oral anti-diabetic drug

  • Specifications

Buy Oral anti-diabetic drug Alogliptin benzoate (Alogliptin) Φαρμακευτικές πρώτες ύλες (CAS 850649-62-6)


Alogliptin benzoate Quick Details

Ονομα προϊόντος Alogliptin benzoate
Συνώνυμα 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate
CAS αριθ. 850649-62-6
Μοριακός τύπος C18H21N5O2.C7H6O2
Μοριακό βάρος 461.52
Εμφάνιση άσπρη σκόνη
Boiling point 671.2°C at 760 mmHg
Χημική δοκιμή 99%min by HPLC
Packing 100g/bag.1Kg/bag or as demand
Application APIs


Alogliptin benzoate Description

Alogliptin is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class.

Alogliptin does not decrease the risk of heart attack and stroke. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of hypoglycemia, and has relatively modest glucose-lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in people whose diabetes cannot adequately be controlled with metformin alone.

Enquiry Form ( we will get back you as soon as possible )


1 + 4 = ?

Maybe you like also

  • κατηγορίες προϊόντων

  • Πρόσφατες δημοσιεύσεις

  • Μερίδιο